Antibody titres and boosting after natural malaria infection in BK-SE36 vaccine responders during a follow-up study in Uganda

Progress and prospects for blood-stage malaria vaccines

(2016) Kazutoyo Miura   Expert Review of Vaccines

A phase 2b randomized, controlled trial of the efficacy of the GMZ2 malaria vaccine in African children

(2016) Sodiomon B. Sirima et al.   VACCINE

Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial

(2015)   LANCET

The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015

(2015) S. Bhatt et al.   NATURE

Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine

(2015) Daniel E. Neafsey et al.   NEW ENGLAND JOURNAL OF MEDICINE

Recent advances in recombinant protein-based malaria vaccines

(2015) Simon J. Draper et al.   VACCINE

Protective Epitopes of the Plasmodium falciparum SERA5 Malaria Vaccine Reside in Intrinsically Unstructured N-Terminal Repetitive Sequences

(2014) Masanori Yagi et al.   PLoS One

The Relationship between RTS,S Vaccine-Induced Antibodies, CD4+ T Cell Responses and Protection against Plasmodium falciparum Infection

(2013) Michael T. White et al.   PLoS One

Phase 1b Randomized Trial and Follow-Up Study in Uganda of the Blood-Stage Malaria Vaccine Candidate BK-SE36

(2013) Nirianne Marie Q. Palacpac et al.   PLoS One

A Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Infants

(2012)   NEW ENGLAND JOURNAL OF MEDICINE

Geographic differentiation of polymorphism in the Plasmodium falciparum malaria vaccine candidate gene SERA5

(2012) Kazuyuki Tanabe et al.   VACCINE

Protection against Malaria by MSP3 Candidate Vaccine

(2011) Sodiomon B. Sirima et al.   NEW ENGLAND JOURNAL OF MEDICINE

First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children

(2011)   NEW ENGLAND JOURNAL OF MEDICINE

A Field Trial to Assess a Blood-Stage Malaria Vaccine

(2011) Mahamadou A. Thera et al.   NEW ENGLAND JOURNAL OF MEDICINE

Plasmodium falciparum serine repeat antigen 5 (SE36) as a malaria vaccine candidate

(2011) Nirianne Marie Q. Palacpac et al.   VACCINE

Evidences of protection against blood-stage infection of Plasmodium falciparum by the novel protein vaccine SE36

(2010) Toshihiro Horii et al.   PARASITOLOGY INTERNATIONAL

Safety and Immunogenicity of the Malaria Vaccine Candidate MSP3 Long Synthetic Peptide in 12–24 Months-Old Burkinabe Children

(2009) Sodiomon B. Sirima et al.   PLoS One